aap Implantate AG (AAQ1.DE)
EUR 1.47
(19.51%)
EUR 1.47
(19.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.62 Million EUR | 16.54% |
| 2022 | 7.4 Million EUR | -27.28% |
| 2021 | 10.17 Million EUR | 8.12% |
| 2020 | 9.41 Million EUR | 26.89% |
| 2019 | 7.41 Million EUR | 1.6% |
| 2018 | 7.3 Million EUR | -7.69% |
| 2017 | 7.91 Million EUR | -12.84% |
| 2016 | 9.07 Million EUR | -38.01% |
| 2015 | 14.63 Million EUR | 17.74% |
| 2014 | 12.43 Million EUR | -25.93% |
| 2013 | 16.78 Million EUR | -5.29% |
| 2012 | 17.72 Million EUR | -0.43% |
| 2011 | 17.8 Million EUR | -5.21% |
| 2010 | 18.78 Million EUR | 4.68% |
| 2009 | 17.94 Million EUR | -30.27% |
| 2008 | 25.72 Million EUR | 4.7% |
| 2007 | 24.57 Million EUR | 282.43% |
| 2006 | 6.42 Million EUR | 12.42% |
| 2005 | 5.71 Million EUR | 16.28% |
| 2004 | 4.91 Million EUR | -99.76% |
| 2003 | 2.04 Billion EUR | 2.74% |
| 2002 | 1.98 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 6.95 Million EUR | 0.0% |
| 2023 Q2 | 6.92 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 FY | 8.62 Million EUR | 16.54% |
| 2022 Q3 | 7.4 Million EUR | -17.82% |
| 2022 Q2 | 9 Million EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 FY | 7.4 Million EUR | -27.28% |
| 2022 Q4 | 7.4 Million EUR | 0.0% |
| 2021 Q3 | 10.17 Million EUR | -10.33% |
| 2021 Q4 | 10.17 Million EUR | 0.0% |
| 2021 FY | 10.17 Million EUR | 8.12% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 11.35 Million EUR | 0.0% |
| 2020 Q3 | 9.41 Million EUR | 23.24% |
| 2020 Q4 | 9.41 Million EUR | 0.0% |
| 2020 Q2 | 7.63 Million EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 9.41 Million EUR | 26.89% |
| 2019 Q4 | 7.41 Million EUR | 0.0% |
| 2019 Q1 | 7.44 Million EUR | 1.92% |
| 2019 Q2 | 9.44 Million EUR | 26.86% |
| 2019 Q3 | 7.41 Million EUR | -21.42% |
| 2019 FY | 7.41 Million EUR | 1.6% |
| 2018 Q1 | 6.98 Million EUR | -11.76% |
| 2018 Q3 | 7.39 Million EUR | 0.96% |
| 2018 Q4 | 7.3 Million EUR | -1.31% |
| 2018 FY | 7.3 Million EUR | -7.69% |
| 2018 Q2 | 7.32 Million EUR | 5.0% |
| 2017 Q2 | 8.17 Million EUR | -8.4% |
| 2017 Q4 | 7.91 Million EUR | -4.11% |
| 2017 FY | 7.91 Million EUR | -12.84% |
| 2017 Q1 | 8.92 Million EUR | -1.7% |
| 2017 Q3 | 8.24 Million EUR | 0.94% |
| 2016 Q4 | 9.07 Million EUR | -6.38% |
| 2016 FY | 9.07 Million EUR | -38.01% |
| 2016 Q3 | 9.69 Million EUR | -5.95% |
| 2016 Q2 | 10.3 Million EUR | -31.91% |
| 2016 Q1 | 15.13 Million EUR | 3.39% |
| 2015 Q3 | 18.11 Million EUR | 8.47% |
| 2015 Q4 | 14.63 Million EUR | -19.18% |
| 2015 Q2 | 16.69 Million EUR | 18.64% |
| 2015 Q1 | 14.07 Million EUR | 13.21% |
| 2015 FY | 14.63 Million EUR | 17.74% |
| 2014 FY | 12.43 Million EUR | -25.93% |
| 2014 Q1 | 9.3 Million EUR | -44.55% |
| 2014 Q2 | 11.1 Million EUR | 19.26% |
| 2014 Q3 | 12.48 Million EUR | 12.42% |
| 2014 Q4 | 12.43 Million EUR | -0.38% |
| 2013 Q3 | 15.91 Million EUR | 32.91% |
| 2013 FY | 16.78 Million EUR | -5.29% |
| 2013 Q2 | 11.97 Million EUR | -32.0% |
| 2013 Q1 | 17.61 Million EUR | -0.64% |
| 2013 Q4 | 16.78 Million EUR | 5.47% |
| 2012 Q1 | 17.72 Million EUR | -0.46% |
| 2012 Q3 | 17.64 Million EUR | 0.85% |
| 2012 FY | 17.72 Million EUR | -0.43% |
| 2012 Q4 | 17.72 Million EUR | 0.43% |
| 2012 Q2 | 17.5 Million EUR | -1.24% |
| 2011 Q1 | 18.64 Million EUR | -0.7% |
| 2011 FY | 17.8 Million EUR | -5.21% |
| 2011 Q4 | 17.8 Million EUR | -1.31% |
| 2011 Q3 | 18.03 Million EUR | 2.24% |
| 2011 Q2 | 17.64 Million EUR | -5.4% |
| 2010 Q4 | 18.78 Million EUR | -10.9% |
| 2010 FY | 18.78 Million EUR | 4.68% |
| 2010 Q3 | 21.07 Million EUR | 16.52% |
| 2010 Q2 | 18.08 Million EUR | 6.78% |
| 2010 Q1 | 16.94 Million EUR | -5.57% |
| 2009 Q2 | 22.65 Million EUR | 0.0% |
| 2009 FY | 17.94 Million EUR | -30.27% |
| 2009 Q4 | 17.94 Million EUR | 0.0% |
| 2008 FY | 25.72 Million EUR | 4.7% |
| 2007 FY | 24.57 Million EUR | 282.43% |
| 2006 FY | 6.42 Million EUR | 12.42% |
| 2005 FY | 5.71 Million EUR | 16.28% |
| 2004 FY | 4.91 Million EUR | -99.76% |
| 2003 FY | 2.04 Billion EUR | 2.74% |
| 2002 FY | 1.98 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 99.533% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 99.533% |
| elexxion AG | 4567.05 EUR | -188752.761% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 215.27 Million EUR | 95.993% |
| Geratherm Medical AG | 11.67 Million EUR | 26.152% |
| Koninklijke Philips N.V. | 17.34 Billion EUR | 99.95% |
| Stratec SE | 246.2 Million EUR | 96.497% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.97% |